Zook Anthony P. 4
4 · NEOGENOMICS INC · Filed May 8, 2025
Insider Transaction Report
Form 4
Zook Anthony P.
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2025-05-06$7.88/sh+18,900$148,919→ 18,900 total(indirect: By Trust)
Holdings
- 11,336
Common Stock
- 8,353
Stock Option (Right to Buy)
Exercise: $14.82From: 2024-08-10Exp: 2033-08-10→ Common Stock (8,353 underlying) - 8,672
Stock Option (Right to Buy)
Exercise: $13.71From: 2025-06-01Exp: 2034-06-01→ Common Stock (8,672 underlying) - 12,254
Restricted Stock Unit
Exercise: $0.00From: 2025-06-01→ Common Stock (12,254 underlying) - 729,927
Stock Option (Right to Buy)
Exercise: $10.44Exp: 2035-04-01→ Common Stock (729,927 underlying) - 421,496
Restricted Stock Unit
Exercise: $0.00→ Common Stock (421,496 underlying)
Footnotes (4)
- [F1]Once vested, the shares of common stock are not subject to expiration.
- [F2]This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on April 1, 2025 and multiplied by 110%.
- [F3]On April 1, 2025, Mr. Zook was granted 729,927 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- [F4]On April 1, 2025, Mr. Zook was granted 421,496 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.